Staubach, P; Onnen, K; Vonend, A et al.
Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trial.Dermatology. Bd. 212. H. 2. 2006 S. 150-9
Schadendorf, D; Ugurel, S; Schuler-Thurner, B et al.
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG.Ann Oncol. Bd. 17. 2006 S. 563-570
Von Stebut, E; Brauninger, W
Development of oil cysts after subcutaneous injection of interferon-alpha and interleukin-2Br J Dermatol. Bd. 155. H. 4. 2006 S. 848-9
Staubach, P
Diagnostik und Therapie verschiedener UrtikariaformenMedReport. Bd. 30. H. 26. 2006 S. 12
Lopez-Kostka, S; Knop, J; Konur, A et al.
Distinct roles for IL-1 receptor type I signaling in early versus established Leishmania major infections.J Invest Dermatol. Bd. 126. H. 7. 2006 S. 1582-9
Steitz, J; Britten, CM; Wolfel, T et al.
Effective induction of anti-melanoma immunity following genetic vaccination with synthetic mRNA coding for the fusion protein EGFP.TRP2.Cancer Immunol Immunother. Bd. 55. H. 3. 2006 S. 246-53
Steitz, J; Buchs, S; Tormo, D et al.
Evaluation of genetic melanoma vaccines in cdk4-mutant mice provides evidence for immunological tolerance against authochthonous melanomas in the skin.Int J Cancer. Bd. 118. H. 2. 2006 S. 373-80
Bork, K; Gül, D; Dewald, G
Hereditary angio-oedema with normal C1 inhibitor in a family with affected women and men.Br J Dermatol. Bd. 154. H. 3. 2006 S. 542-545
Bork, K
Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations.Immunol Allergy Clin North Am. Bd. 26. H. 4. 2006 S. 709-24
Longhurst, HJ; Bork, K
Hereditary angioedema: causes, manifestations and treatment.Hosp Med. Bd. 67. H. 12. 2006 S. 654-657